Key statistics
As of last trade AbbVie Inc (4AB0:FRA) traded at 18.40, -7.07% below its 52-week high of 19.80, set on Oct 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 18.40 |
Low | 18.40 |
Bid | 16.20 |
Offer | 18.10 |
Previous close | 18.40 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.6259 EUR |
---|---|
Annual div yield (ADY) | 3.38% |
Div ex-date | Oct 15 2024 |
Div pay-date | Nov 22 2024 |
Next div ex-date | Jan 15 2025 |
Next div pay-date | Feb 24 2025 |
Data delayed at least 15 minutes, as of Nov 11 2024 08:59 GMT.
More ▼
Press releases
- PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
- Seaport Therapeutics Names Lauren White as Chief Financial Officer
- NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines